Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Zoledronic Acid × Breast × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2 CNS 2 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 67 pembrolizumab 65 Letrozole 64 Trastuzumab 58 Paclitaxel 58 Specimen Handling 44 Capecitabine 43 Magnetic Resonance Spectroscopy 40 Tamoxifen 39 pertuzumab 38 Anastrozole 37 Cyclophosphamide 36 Carboplatin 34 exemestane 33 abemaciclib 33 ribociclib 32 Biopsy 32 Radiotherapy 28 palbociclib 26 Docetaxel 26 olaparib 24 trastuzumab deruxtecan 23 Surveys and Questionnaires 20 130-nm albumin-bound paclitaxel 20 eribulin 19 Doxorubicin 19 Taxes 16 Standard of Care 16 Gemcitabine 16 sacituzumab govitecan 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03664687 2026-02-09

REaCT-ZOL

Ottawa Hospital Research Institute

Phase 4 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡